Literature DB >> 29106035

Genetic association of HLA-DRB1 multiple polymorphisms with dermatomyositis in Chinese population.

J M Lin1,2, Y B Zhang3, Q L Peng4, H B Yang4, J L Shi4, M L Gu3,5, W M Zhao1, G C Wang4.   

Abstract

Genetic variation in HLA plays an important role in the pathogenesis of dermatomyositis (DM). The aim of this study was to investigate the association of HLA class II with DM in China. Two hundred and twenty-four DM patients and 300 healthy controls were randomly enrolled at China-Japan Friendship Hospital. High-resolution typing of HLA-DRB1 alleles was performed by sequencing based typing. The HLA-DQA1 and HLA-DQB1 alleles were determined by polymerase chain reaction sequence-specific primers. The frequencies of HLA-DRB1*09:01 (28.6% vs 11.3%, P < .0001, odds ratio, OR = 3.14, 95% confidence interval, CI = 2.47-3.99) and HLA-DRB1*12:01 (29.0% vs 11.0%, P < .0001, OR = 3.30, 95% CI = 2.59-4.20) in DM patients were significantly higher than that in healthy controls. No significant difference was found in HLA-DQA1 or DQB1 alleles between DM patients and healthy controls. Furthermore, DM patients with anti-melanoma differentiation-associated gene 5 antibody (anti-MDA5) had a significantly higher frequency of HLA-DRB1*12:01 compared to that for patients without anti-MDA5 (P < .0001, OR = 4.77, 95% CI: 2.29-9.93). Multivariate binary logistic regression analysis was performed to identify the risk factors for interstitial lung disease. The HLA-DRB1*09:01 allele was a poor prognostic factor (P = .01, OR = 9.21, 95% CI: 1.47-57.50) for DM patients with anti-MDA5 autoantibody. In summary, our findings indicate that HLA-DRB1*09:01 and HLA-DRB1*12:01 alleles may contribute to susceptibility of adult DM in Han Chinese population. In addition, the DRB1*12:01 genotype is significantly associated with the presence of anti-MDA5 antibody in DM patients.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  dermatomyositis; genetic; human leukocyte antigen; myositis-specific autoantibodies

Mesh:

Substances:

Year:  2017        PMID: 29106035     DOI: 10.1111/tan.13171

Source DB:  PubMed          Journal:  HLA        ISSN: 2059-2302            Impact factor:   4.513


  8 in total

1.  Identification of immune-related biomarkers associated with tumorigenesis and prognosis in skin cutaneous melanoma.

Authors:  Zhong-Hao Ji; Wen-Zhi Ren; Shuo Yang; Dong-Xu Wang; Zi-Ping Jiang; Chao Lin; Ye Jin; Wen-Tai Tian
Journal:  Am J Cancer Res       Date:  2022-04-15       Impact factor: 5.942

Review 2.  Dermatomyositis Clinical and Pathological Phenotypes Associated with Myositis-Specific Autoantibodies.

Authors:  Paige W Wolstencroft; David F Fiorentino
Journal:  Curr Rheumatol Rep       Date:  2018-04-10       Impact factor: 4.592

3.  Geographical Latitude Remains as an Important Factor for the Prevalence of Some Myositis Autoantibodies: A Systematic Review.

Authors:  Andrea Aguilar-Vazquez; Efrain Chavarria-Avila; Oscar Pizano-Martinez; Alejandra Ramos-Hernandez; Lilia Andrade-Ortega; Edy-David Rubio-Arellano; Monica Vazquez-Del Mercado
Journal:  Front Immunol       Date:  2021-04-22       Impact factor: 7.561

4.  Disease characteristics and clinical outcomes of adults and children with anti-MDA-5 antibody-associated myositis: a prospective observational bicentric study.

Authors:  Sai Kumar Dunga; Chengappa Kavadichanda; Latika Gupta; R Naveen; Vikas Agarwal; Vir Singh Negi
Journal:  Rheumatol Int       Date:  2021-05-29       Impact factor: 2.631

5.  Recurrence of anti-MDA5 antibody-positive clinically amyopathic dermatomyositis after long-term remission: A case report.

Authors:  Yushiro Endo; Tomohiro Koga; Midori Ishida; Yuya Fujita; Sosuke Tsuji; Ayuko Takatani; Toshimasa Shimizu; Remi Sumiyoshi; Takashi Igawa; Masataka Umeda; Shoichi Fukui; Ayako Nishino; Shin-Ya Kawashiri; Naoki Iwamoto; Kunihiro Ichinose; Mami Tamai; Hideki Nakamura; Tomoki Origuchi; Masataka Kuwana; Yuji Hosono; Tsuneyo Mimori; Atsushi Kawakami
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

Review 6.  Genetics of idiopathic inflammatory myopathies: insights into disease pathogenesis.

Authors:  Simon Rothwell; Hector Chinoy; Janine A Lamb
Journal:  Curr Opin Rheumatol       Date:  2019-11       Impact factor: 5.006

Review 7.  Dermatomyositis autoantibodies: how can we maximize utility?

Authors:  Luqman Mushila Hodgkinson; Tiffany Tingshuen Wu; David Franklin Fiorentino
Journal:  Ann Transl Med       Date:  2021-03

8.  Dermatomyositis Which Was Double Positive for Anti-MDA5 and Anti-ARS Antibodies That Was Successfully Treated by Intensive Immunosuppressive Therapy.

Authors:  Satoshi Hama; Misako Higashida-Konishi; Mitsuhiro Akiyama; Tatsuya Shimada; Hiroshi Takei; Keisuke Izumi; Hisaji Oshima; Yutaka Okano
Journal:  Intern Med       Date:  2022-04-01       Impact factor: 1.271

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.